A specimen processing platform designed to meet the requirements of efficient hemostasis testing
Diagnostica Stago introduced the STA Workcell Max, a specimen processing platform designed to meet the rigorous requirements of efficient hemostasis testing. With a loading capacity of 300 specimens at a time, STA Workcell Max automatically loads and balances centrifuge buckets, and prepares platelet poor plasma by centrifuging specimens using hemostasis-specific criteria. Intelligent rack preparation enables optimized routing to the designated STA R Max analyzer. Specimens are held inside of up to four Stago STA R Max systems until results are validated, thus ensuring rapid availability in the case of additional or reflex testing. Racks are automatically unloaded from the instrument and held in the output module. By automating front-end specimen processing, rack preparation and specimen routing, the STA Workcell Max enables allocation of skilled laboratory technologists for other more complex, value-added tasks.
The STA Coag Expert data management platform powering the STA Workcell Max automation line, transforms lab QC and patient results into robust, traceable, actionable clinical insights. STA Coag Expert delivers full traceability, from operator activity to reagent and consumable lot identification for each data point. Also included, are connectivity capabilities to auto-upload QC results into a real-time peer comparison program, MyExpertQC. An upcoming suite of digital services, including remote monitoring and proactive instrument alerts, will further enhance the value of STA Coag Expert by reducing TAT and increasing system efficiency
For patients undergoing cardiovascular or major orthopedic surgeries, HemoSonics, a Stago Group Company, presents the Quantra QPlus System which was recently cleared through the FDA de novo process. Based on innovative ultrasound technology — SEER (Sonic Estimation of Elasticity via Resonance) sonorheometry, the Quantra system provides a rapid assessment of the viscoelastic properties of a clot at the point-of-care that can aid in the management of critical bleeding.
Results are delivered on-screen in 15 minutes or less using closed-tube, whole blood specimens in a cartridge-based system that requires less than 60 seconds hands-on time. The Quantra QPlus System provides actionable, easy-to-read results designed to enable patient-specific transfusion decisions at the most critical moment. The speed and clarity of results allow for a simple, rapid decision-making process aimed to help clinicians provide the right therapy to control bleeding, to the right patient, at the right time. Guided by the mission of HemoSonics, the goal of the Quantra system is to support appropriate utilization of precious and costly resources, reduce risk and improve patient care in a critical setting.
